SCHEMBL12239182

SCHEMBL12239182

CCc1cnc(N2CCC(Oc3ccc(CN4CCCCC4C)cc3Cl)CC2)nc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
MAPT P10636 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CSNK2A1 P68400 2/20 0.42
KDM4E B2RXH2 1/20 0.41
GPR119 Q8TDV5 3/20 0.41
SCD O00767 3/20 0.41
HRH3 Q9Y5N1 4/20 0.40
MAPK1 P28482 1/20 0.38
SCN1A P35498 2/20 0.38
SCN8A Q9UQD0 2/20 0.38
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12239172 0.87 SMN1; SMN2 (0.43) SMN1; SMN2CSNK2A1GPR119SCDHRH3
SCHEMBL1005456 0.84 GPR119 (0.45) KDM4EGPR119SCN1ASCN8A
SCHEMBL1006689 0.84 GPR119 (0.40) ALDH1A1CSNK2A1GPR119SCDSCN1A
SCHEMBL12239186 0.84 SCD (0.42) SMN1; SMN2CSNK2A1GPR119SCDSCN1A
SCHEMBL1005428 0.83 SCD (0.47) CSNK2A1GPR119SCD
SCHEMBL12239176 0.83 CSNK2A1 (0.45) CSNK2A1GPR119SCDSCN1ASCN8A
SCHEMBL12239179 0.83 GPR119 (0.44) CSNK2A1GPR119SCD
SCHEMBL1003971 0.82 SCD (0.46) CSNK2A1GPR119SCD
SCHEMBL12262498 0.81 SCN8A (0.42) SMN1; SMN2CSNK2A1GPR119SCDSCN1A
SCHEMBL12239188 0.81 GPR119 (0.42) SMN1; SMN2CSNK2A1GPR119SCDSCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110263557-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263557-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR55, NR1H2 ALDH1A1 2341/4885MAPT 4750/4885CRHBP 1804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.